血清肌酐-胱抑素C衍生指数可预测社区老年人肌少症发生与进展
该前瞻性队列纳入671名社区老年人(中位年龄72岁,男性35.0%),按性别特异性三分位分组评估总身体肌肉质量指数(TBMM)与肌少症发生或进展的关联。随访期间7.5%的参与者出现肌少症发生或进展,较高TBMM三分位组风险显著降低。将TBMM纳入预测模型可提高判别能力(AUC从0.771升至0.856)。
要点
- TBMM较高三分位组肌少症发生或进展风险显著低于最低三分位组。
- 将TBMM加入预测模型可提升判别能力,AUC由0.771提高至0.856。
- TBMM基于肌酐与胱抑素C衍生,可作为社区老年人肌少症早期风险分层工具。
核心结论
- TBMM是社区老年人肌少症发生与进展的强预测因子,可用于早期风险分层和及时干预。
研究设计与样本
- 前瞻性队列研究纳入671名社区老年人,中位年龄72岁(IQR 68-76),男性占35.0%。
- 肌少症依据亚洲肌少症工作组(AWGS)标准诊断,参与者按性别特异性TBMM三分位分组。
- 结局定义为肌少症发生或进展,进展指基线已患肌少症者发展为严重肌少症。
- 采用Cox比例风险回归模型和时间依赖ROC曲线分析评估关联。
主要发现
- 随访期间7.5%的参与者出现肌少症发生或进展。
- 与TBMM第1三分位组相比,第2三分位组调整后风险比为0.18(95%CI:0.07-0.42;P<.001)。
- 与TBMM第1三分位组相比,第3三分位组调整后风险比为0.15(95%CI:0.06-0.40;P<.001)。
- 将TBMM纳入预测模型后判别能力提高,AUC从0.771升至0.856(P=.01)。
关键数值与推荐
- 肌少症诊断采用亚洲肌少症工作组(AWGS)标准。
- TBMM按性别特异性三分位分层,以第1三分位为参照。
- 结局为肌少症发生或进展,进展定义为基线肌少症者发展为严重肌少症。
临床怎么用
- 可利用基于肌酐和胱抑素C计算的TBMM对社区老年人进行肌少症风险早期分层。
- 对TBMM处于较低三分位者应加强肌少症筛查并及时启动干预。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Identifying individuals at risk of sarcopenia incidence or progression remains challenging. Serum creatinine- and cystatin C-derived indices are objective markers of muscle metabolism; however, their predictive value for sarcopenia progression remains uncertain. This study evaluated the association between a creatinine- and cystatin C-derived index, the total body muscle mass index (TBMM) and sarcopenia incidence or progression in community-dwelling older adults. METHODS: This prospective cohort study included 671 older adults (median age 72 [IQR 68-76] years; 35.0% male). Sarcopenia was diagnosed using the Asian Working Group for Sarcopenia criteria. Participants were stratified by sex-specific tertiles of TBMM. The outcome was defined as incident or progressive sarcopenia, with progression defined as the development of severe sarcopenia in those affected at baseline. Cox proportional hazards regression models and time-dependent receiver operating characteristic curve analyses were used to assess the associations. RESULTS: During follow-up, 7.5% of participants experienced sarcopenia incidence or progression. Higher TBMM tertiles were significantly associated with a lower risk, with adjusted hazard ratios of 0.18 (95% confidence interval [CI]: 0.07-0.42; P < .001) and 0.15 (95% CI: 0.06-0.40; P < .001) for Tertiles 2 and 3, respectively, compared with Tertile 1. Incorporating TBMM into predictive models improved discrimination (area under the curve increased from 0.771 to 0.856, P = .01). CONCLUSIONS: TBMM is a strong predictor of sarcopenia incidence and progression in community-dwelling older adults. Given its accessibility and accuracy, TBMM may serve as a valuable tool for early risk stratification and timely interventions in clinical practice.
引用
- Matsuzawa R, Nagai K, Mori T, et al. A serum creatinine-cystatin C-derived index as a predictive marker for sarcopenia incidence and progression in community-dwelling older adults: a prospective cohort study. Age Ageing. 2025. PMID: 40613667. doi:10.1093/ageing/afaf185
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。